Scientia is conducting a study for a potential treatment of Parkinson's' disease.
This study involves an oral capsule but Parkinson’s Disease, a progressive neurodegenerative disorder affecting 1-2% of individuals over 65 years of age, with the prevalence expected to increase due to global aging.
For this trial we need the help of healthy males and females aged from 18-65 (inclusive).
This requires an in-house stay of 4 nights, with 1 follow up visit and an additional phone consultation.
Healthy volunteers will be reimbursed for their time.